Instructed to discontinue the dose was administered a heavy inflammatory abnormalities if administered stop instructions
[ad_1]
new anti-cancer drug "opzi-Bo" heart op zebo in 60 patients cause heavy inflammation in the heart and died, undeniable causation is the Ministry of health, labour and welfare, pharmaceutical company, abnormalities in patients, such as the inclusion of an attached document.
[ad_2]
Read more at Instructed to discontinue the dose was administered a heavy inflammatory abnormalities if administered stop instructions
JAPANESE
新しいタイプの抗がん剤「オプジーボ」を投与された６０代の患者が心臓に重い炎症を起こして死亡し、厚生労働省は因果関係が否定できないとして、製薬会社に対し、患者に異常が見られた場合には投与を中止することなどを添付文書に盛り込むよう指示しました。